Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 12:6:203.
doi: 10.3389/fonc.2016.00203. eCollection 2016.

Incidence, Treatment, and Survival Patterns for Sacral Chordoma in the United States, 1974-2011

Esther Yu  1 , Paul P Koffer  1 , Thomas A DiPetrillo  2 , Timothy J Kinsella  3
Affiliations

Incidence, Treatment, and Survival Patterns for Sacral Chordoma in the United States, 1974-2011

Esther Yu et al. Front Oncol. .

Abstract

Introduction: Sacral chordomas represent one half of all chordomas, a rare neoplasm of notochordal remnants. Current NCCN guidelines recommend surgical resection with or without adjuvant radiotherapy or definitive radiation for unresectable cases. Recent advances in radiation for chordomas include conformal photon and proton beam radiation. We investigated incidence, treatment, and survival outcomes to observe any trends in response to improvements in surgical and radiation techniques over a near 40-year time period.

Materials and methods: Three hundred forty-five microscopically confirmed cases of sacral chordoma were identified between 1974 and 2011 from the surveillance, epidemiology, and end results program of the National Cancer Institute. Cases were divided into three cohorts by calendar year, 1974-1989, 1990-1999, and 2000-2011, as well as into two groups by age ≤65 versus >65 to investigate trends over time and age via Chi-square analysis. Kaplan-Meier analyses were performed to determine effects of treatment on survival. Multivariate Cox regression analysis was performed to determine predictors of overall survival (OS).

Results: Five-year OS for the entire cohort was 60.0%. OS correlated significantly with treatment modality, with 44% surviving at 5 years with no treatment, 52% with radiation alone, 82% surgery alone, and 78% surgery and radiation (p < 0.001). Age >65 was significantly associated with non-surgical management with radiation alone or no treatment (p < 0.001). Relatively, fewer patients received radiation between 2000 and 2011 compared to prior time periods (p = 0.03) versus surgery, for which rates which did not vary significantly over time (p = 0.55). However, 5-year OS was not significantly different by time period. Age group and treatment modality were predictive for OS on multivariate analysis (p < 0.001).

Conclusion: Surgery remains an important component in the treatment of sacral chordomas in current practice. Fewer patients were treated with radiation more recently despite advances in photon and proton beam radiation. OS remains unchanged. Additional analyses of margin status, radiation modality, and local control in current practice are warranted.

Keywords: IMRT; SBRT; chordoma; heavy ion; protons.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trends in surgery and radiotherapy use.
Figure 2
Figure 2
Overall survival by treatment modality.
See this image and copyright information in PMC

References

    1. Hsieh PC, Xu R, Sciubba DM, McGirt MJ, Nelson C, Witham TF, et al. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients. Spine (Phila Pa 1976) (2009) 34(20):2233–9.10.1097/BRS.0b013e3181b61b90 - DOI - PubMed
    1. Sciubba DM, Chi JH, Rhines LD, Gokaslan ZL. Chordoma of the spinal column. Neurosurg Clin N Am (2008) 19(1):5–15.10.1016/j.nec.2007.09.006 - DOI - PubMed
    1. York JE, Kaczaraj A, Abi-Said D, Fuller GN, Skibber JM, Janjan NA, et al. Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery (1999) 44(1):74–9; discussion 79–80.10.1097/00006123-199901000-00041 - DOI - PubMed
    1. Romero J, Cardenes H, la Torre A, Valcarcel F, Magallon R, Regueiro C, et al. Chordoma: results of radiation therapy in eighteen patients. Radiother Oncol (1993) 29(1):27–32.10.1016/0167-8140(93)90169-9 - DOI - PubMed
    1. Schulz-Ertner D, Nikoghosyan A, Thilmann C, Haberer T, Jäkel O, Karger C, et al. Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys (2004) 58(2):631–40.10.1016/j.ijrobp.2003.09.041 - DOI - PubMed

LinkOut - more resources